The future of real-world evidence
Mission critical: accelerating RWE adoption, investment, and application in today’s health care market
The use of real-world evidence (RWE), or evidence derived from data generated outside clinical trials, is developing dramatically.
Transforming the future of clinical development
Biopharma R&D has changed the face of disease management over the years. Yet many in the field admit that clinical development has fallen behind in adopting digital technologies, which have the potential to change how research organizations can engage with patients
2018 Global life sciences outlook
Innovating life sciences in the fourth industrial revolution: Embrace, build, grow
With the arrival of the fourth industrial revolution, the life sciences sector is also taking on the transformative journey that emerging technologies offer.
The challenge of compliance in the life sciences supply chain
The life sciences industry operates in one of the world’s most regulated environments. Global life sciences supply chains are lengthy and complex, shaped by many internal and external factors.
Life Sciences and Health Care Predictions 2022
The future awakens
Challenging times lie ahead arising from a growing and ageing population and a tidal wave of chronic diseases. Life Sciences and Health Care Predictions 2022 provide six new predictions of what the life sciences and health care ecosystem might look like in 2022
2016 Global life sciences outlook
Moving forward with cautious optimism
Explore the top issues facing global life sciences companies and stakeholders as they seek to address the anticipated challenges and issues that lie ahead in 2016.
Healthcare and Life Sciences Predictions 2020
Taxing times ahead
Tax is a hot topic right now for big business and will have major repercussions for the healthcare and life sciences industry. This paper explores the key tax challenges facing the industry and provides thought-provoking ideas to enable you to discuss future scenarios and how best to respond.